...
首页> 外文期刊>Developmental Immunology: Journal of Immunology Research >Glucocorticoid-Induced TNFR-Related Protein Stimulation Reverses Cardiac Allograft Acceptance Induced by CD40-CD40L Blockade
【24h】

Glucocorticoid-Induced TNFR-Related Protein Stimulation Reverses Cardiac Allograft Acceptance Induced by CD40-CD40L Blockade

机译:糖皮质激素诱导的TNFR相关蛋白刺激逆转了CD40-CD40L阻断诱导的心脏同种异体移植的接受性。

获取原文
   

获取外文期刊封面封底 >>

       

摘要

CD40-CD40L blockade has potent immunosuppressive effects in cardiac allograft rejection but is less effective in the presence of inflammatory signals. To better understand the factors that mediate CD40-CD40L blockade-resistant rejection, we studied the effects of stimulation through glucocorticoid-induced TNFR-related protein (GITR), a costimulatory protein expressed by regulatory and effector T cells. Stimulation of CD40−/− or wild-type recipient mice treated with anti-CD40L mAb (WT+anti-CD40L) and with agonistic anti-GITR mAb resulted in cardiac allograft rejection. GITR stimulation did not induce rejection once long-term graft acceptance was established. In vitro, GITR stimulation increased proliferation of effector T cells and decreased regulatory T cell (Treg) differentiation in both treatment groups. GITR-stimulated CD40−/− recipients rejected their allografts more rapidly compared to GITR-stimulated WT+anti-CD40L recipients, and this rejection, characterized by a robust Th2 response and significant eosinophilic infiltrate, could be mediated by CD4+ T cells alone. In contrast, both CD4+ and CD8+ T cells were required to induce rejection in GITR-stimulated WT+anti-CD40L-treated recipients, and the pathology of rejection was less severe. Hence, early GITR stimulation could initiate graft rejection despite CD40 deficiency or anti-CD40L mAb treatment, though the recipient response was dependent on the mechanism of CD40-CD40L disruption.
机译:CD40-CD40L阻断剂在心脏同种异体移植排斥反应中具有强大的免疫抑制作用,但在存在炎症信号时效果较差。为了更好地理解介导CD40-CD40L阻滞性排斥的因素,我们研究了糖皮质激素诱导的TNFR相关蛋白(GITR)刺激的作用,该蛋白由调节性T细胞和效应T细胞表达。用抗CD40L mAb(WT +抗CD40L)和激动性抗GITR mAb治疗的CD40-/-或野生型受体小鼠的刺激导致心脏同种异体移植排斥。建立长期移植物接受后,GITR刺激不会引起排斥反应。在体外,在两个治疗组中,GITR刺激均增加了效应T细胞的增殖并降低了调节性T细胞(Treg)的分化。与GITR刺激的WT +抗CD40L受体相比,GITR刺激的CD40-/-受体更快地拒绝了他们的同种异体移植物,并且这种排斥反应的特征是强大的Th2反应和显着的嗜酸性粒细胞浸润,可以单独由CD4 + T细胞介导。相反,在GITR刺激的WT +抗CD40L处理的受体中,诱导CD4 +和CD8 + T细胞都需要排斥,并且排斥的病理性较轻。因此,尽管受体应答依赖于CD40-CD40L破坏的机制,尽管CD40缺乏或抗CD40L mAb治疗,早期的GITR刺激仍可引发移植排斥反应。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号